Halitosis: A Review of The Literature On Its Prevalence, Impact and Control
Halitosis: A Review of The Literature On Its Prevalence, Impact and Control
Halitosis: A Review of The Literature On Its Prevalence, Impact and Control
net/publication/269767667
CITATIONS READS
52 4,872
3 authors, including:
All content following this page was uploaded by Ezi Akaji on 10 August 2015.
Summary: Halitosis is the offensive or disagreeable odour that may emanate from the mouth. In 80%–90% of cases,
bacterial activities especially on the dorsum of the tongue are implicated. Current studies on halitosis accessed from
electronic databases were appraised in the light of prevalence, impact and control of halitosis. Halitosis has a world-
wide occurrence with a prevalence range of 22% to 50%. Due to the associated social and psychological effects, it
should be taken seriously in all affected patients. Oral healthcare professionals ought to be well informed, because
their office(s) are usually the first points of call for the affected patients.
Oral Health Prev Dent 2014;12:297-304 Submitted for publication: 17.08.13; accepted for publication:08.01.14
doi: 10.3290/j.ohpd.a33135
articles were accessed and stored on a CD-ROM. Tangerman and Winkel,88 in their assessment of
Sorting was done to exclude all publications before 58 subjects without periodontal disease but with
1990 while those from 1990 and 2012 were includ- complaint of malodour, found 10.4% of them with
ed. The authors read the articles and extracted data halitosis from non-oral sources. They also reported
on prevalence, impact and control of halitosis. If any dimethyl sulfide (CH3SCH3) and methyl mercaptan
author had more than one article on halitosis or its (CH3SH) as the main VSCs associated with extra-
correlates, the most suitable for each subheading oral and intra-oral halitosis, respectively.12 In their
under focus was selected; this was done to accom- study on daily variation of oral malodour and related
modate as many authors’ views as possible. factors in community-dwelling elderly subjects, Sam-
nieng et al72 found a significant association between
the concentration of CH3SCH3 with systemic diseas-
PREVALENCE OF HALITOSIS es and routine intake of medications at all times of
measurements. Subjects with systemic disease and
Halitosis is a problem that has plagued people for routine intake of medicines (80.7%) tended to have
thousands of years; it ranks third amongst the rea- a higher concentration of CH3SCH3 than their coun-
sons for patients’ visit to the dentist.14,24 It can be terparts. Although halitosis from non-oral sources is
detected organoleptically (i.e. by nose) and instru- generally not common, records from a multidisciplin-
mentally using sulfide monitors or gas chromatogra- ary breath clinic show that the most frequent non-
phy,57,66,68,96 although results of these different oral source is in the ear, nose and throat area.21,22
methods do not always agree.15 The prevalence of
halitosis differs across the globe due to variations
in the perception of odours among people of differ- IMPACT OF HALITOSIS ON THE INDIVIDUAL
ent races and cultures, absence of uniformity in AND SOCIETY
evaluation as well as a disparity between self-per-
ceived and clinically detected halitosis re- Halitosis has both medical and social aspects, the
ports.11,44,63 However, the overall prevalence ranges latter being responsible for most of the concern in
from 22% to 50%, being higher when self-reported recent times.9,19,73 Some phrases used to describe
than clinically detected.18,71 Table 2 shows the prev- it in the literature include social stigma,6 social
alences of halitosis extracted from some studies. health problem,63 universal medico-social prob-
Significant differences
Arowojolu were found in the
14.5% among attendees
and Ibadan, 255 consecutive Organoleptic prevalence of halitosis
of the periodontology
Dosunmu, Nigeria patients (16–74 years) assessment according to age group,
clinic
20047 oral hygiene status and
social class
Significantly higher
Söder et Clinically rated
Sweden Swedish men/ 1681 41 (2.4%) prevalence probing depth and
al, 200080 halitosis
gingival index
lem63 and social-life killer.9 Hence, it could consti- es such as use of mints and chewing gum, mouth-
tute a handicap leading to withdrawal from social wash, sprays and dental floss, increased frequency
circles by affected individuals.24,34 Data analysed of toothbrushing and toothbrushing force were ap-
from 465 patients who attended the halitosis clinic plied to mask bad breath.10,14,49,58 Thus, proper pro-
at the University of Basel over a 7-year period re- fessional guidance in employing some of these
vealed that social life was affected in about 388 of practices is strongly encouraged to avoid unwanted
them.97 Sufferers of halitosis can also be plagued side effects, such as tooth-wear lesions and caries.
with anxiety regardless of whether the condition is Other challenges that can ensue from halitosis
real or imagined.4,75,90 Anxiety in this context is are low self-esteem and self-confidence, hampered
more or less phobia-mediated, leading to avoidance intimate relationships such as dating and marriage,
of dental visits, poorer oral health and ultimately to decreased quality of life, unfulfilled career aspira-
a heightened or real oral malodour.75 Clinicians ob- tions, loneliness, depression, substance abuse,
served a trend among victims: behavioural practic- dropping out of school, suicidal tendencies and di-
vorce.3,4,9 Ancient Hebraic texts (the Talmud) pro- • TN-2: Oral prophylaxis, professional cleaning and
vided legal backing to broken marriages if one part- treatment of oral diseases, especially periodon-
ner had oral malodour and similar references were tal diseases.
found in writings from Greek, Roman, early Chris- • TN-3: Referral to a physician or medical specialist.
tian and Islamic cultures.73 • TN-4: Explanation of examination data, further pro-
The effect of halitosis goes beyond the immedi- fessional instruction, education and reassurance.
ate sufferer as relatives and friends also share in • TN-5: Referral to a clinical psychologist, psychia-
the burden.9,19 Apart from the awkward scenario trist or other psychological specialist.
created by the condition, relatives may need to re-
assure or counsel the sufferers about their bad Dental clinicians may implement the TN-1 modality
breath.9,55 Delanghe et al22 reported that more than as treatment of physiologic halitosis; TN-1 and TN-2
70% of the attendees at a Belgian breath clinic were apply to oral pathological halitosis, while TN-1 and
advised by others to seek treatment; in a suburban TN-4 would suffice for pseudo-halitosis.50,94 Treat-
health facility in Nigeria, 31.7% and 24.4% were in- ment of extraoral halitosis should be performed by
formed of the symptoms by friends and spouses, a physician or medical specialist in line with TN-3,
respectively, before they visited the clinic.55 From while treatment of halitophobia should be by a clin-
an economic point of view, productive hours are lost ical psychologist, psychiatrist or psychologist (TN-
while sufferers seek solutions to their predicament, 5).50,94 TN-2 procedures entail mechanical reduc-
with a concurrent boom in the mouthwash indus- tion of tongue coating as well as gingivitis and
try.9,55 This is evidenced by the $700 million dollars periodontitis therapy.50,59 Some clinicians have ad-
spent on mouthwashes by Americans in 2000 and vised adequate oral hygiene at home: toothbrush-
more than $850 million dollars in the previous ing, flossing and moderate tongue scraping or
years.52,67 Meningaud et al49 reported over 2 billion brushing using an infant toothbrush or a small
dollars spent annually on products to mask halito- tongue brush to remove the microbial causal
sis. It can be concluded that a great deal of social, agent(s).53,54,85 Chemical agents and use of natural
psychological and economic resources are devoted ingredients such as mouthrinses containing chlor-
to halitosis both at the individual and community hexidine, triclosan, cetylpyridinium chloride, essen-
levels, since its impact cuts across culture, religion, tial oils or hydrogen peroxide could also be pre-
race, sex and social taboos.63,73 scribed.18,35,64 Metal ions, e.g. stannous, zinc and
copper ions, are useful in controlling halitosis
through their anti-plaque properties, that is, by the
PREVENTION AND CONTROL OF HALITOSIS oxidation of either thiol groups in the sulfur-contain-
ing precursors of VSCs or the odoriferous substanc-
Halitosis, a condition with known microbial and bio- es themselves to non-volatile substances.35 Chlor-
chemical parameters, can be prevented and/or ine dioxide is another antibacterial mouthwash that
controlled.2,41,44,85 Each case is treated differently may be used against oral malodour.28,79 Two sepa-
depending on its origin, making a holistic approach rate clinical trials by the same research group found
necessary.53 Before a treatment plan can be devel- it effective as an oxidant in both healthy and af-
oped for any patient, an accurate diagnosis based fected subjects for the control of oral malodour.77,78
on the patient’s history, physical examination, or- Other agents against halitosis include bacterio-
ganoleptic assessment and evaluation of any la- cin-producing microorganisms (probiotics) such as
boratory tests must be made.48 Also, a review of Streptococcus salivarius K12 and Lactobacillus sali-
significant aspects of the patient’s family and so- varius WB21.16,32,46 Here, the objective is to pre-
cial history (such as dietary and smoking habits), vent re-establishment of undesirable bacteria,
drug histories, illnesses, hospitalisations and sur- thereby limiting the re-occurrence of oral malodour
geries are invaluable in reaching an appropriate di- over a prolonged period, since probiotics are keen
agnosis.48 In 1999, Miyazaki et al50 established competitors of oral malodour bacteria.11 Herbal
the recommended classification for halitosis with and natural products have also been advocated for
the corresponding treatment needs: the control of halitosis.31,62,76,81,82,86 Green tea
• TN-1: Explanation of halitosis and instructions mouthwash containing green tea extracts demon-
for oral hygiene (support and reinforcement of a strated an appreciable effect among 60 patients
patient’s own self-care for further improvement with gingivitis who had at least 80 ppb VSCs in
of his/her oral hygiene). mouth air. The reduction in malodour observed was
In periodontally healthy
Blinded crossover Tongue scraping and interdental Reduced VSCs in morning
Faveri et subjects, tongue scraping was
study involving 19 cleaning done thrice a day for 7 breath in subjects with healthy
al, 200625 an important method of
volunteers days, then washouts periodontium
reducing halitosis
Experimental study
Zinc cations added to CHX
involving 16 dental
Quirynen Rinsing with CHX-Alc, CHX-CPC- mouthrinse yielded 40% Sulfur binding to zinc produced
students who rinsed
et al, Zn, or AmF/SnF 2 mouthrinse, reduction in VSC, 80% an enhanced effect of halitosis
with one of the 3
200260 used twice daily for 1 week reduction in organoleptic reduction
solutions in a
expired ratings
randomised order
Double-blind ran-
Van CHX-CPC-Zn was more
domised study Randomised daily rinse with 1 Beneficial effect on halitosis
Steen- effective in reducing organo-
involving 12 (aged of the following: CHX, CHX- NaF although the mode of action
berghe et leptic scores and sulfide
21–23 years) medical or HX-CPC-Zn was unclear
al, 200192 monitoring readings
student volunteers
Randomised double- Divided subjects into 2 groups Concentrations of VSCs Further investigations on
Shinada blind crossover, that rinsed with either mouth- decreased for those who used long-term effects of ClO2 and
et al, placebo-controlled trial wash containing chlorine dioxide the experimental mouthwash its effect on periodontal
201078 involving 15 male volun- (ClO2) or placebo mouthwash for 7 days; plaque and tongue diseases and plaque accumula-
teers (19–38 years) without ClO2 for 7 days coating also decreased tion are needed
Abbreviations: CHX = chlorhexidine (0.2%); CHX-Alc = 0.2% chlorhexidine-alcohol mouthrinse; CHX-CPC-Zn = 0.05% CHX + 0.05% cetylpyridinium
chloride + 0.14% zinc lactate mouthrinse; AmF/SnF = an amine fluoride/stannous fluoride (125 ppm F-/125 ppm F-) containing mouthrinse; CPC
= cetylpyridinium chloride; CHX-NaF = 0.12% chlorhexidine + 0.05% sodium fluoride; CHX-CPC-Zn = 0.05% chlorhexidine + 0.05 cetylpyridinium
+ 0.14% zinc lactate; VSCs = volatile sulfur compounds.
21. Delanghe G, Ghyselen J, Bollen C, van Steenberghe D, 40. Krespi YP, Shrime MG, Kacker A. The relationship between
Vandekerchove BN, Feenstra L. An inventory of patients’ oral malodor and volatile sulfur compound-producing bac-
response to treatment at a multidisciplinary breath odor teria. Otolaryngol Head Neck Surg 2006;135:671–676.
clinic. Quintessence Int 1999;30:307–310. 41. Lee SS, Zhang W, Li Y. Halitosis update: a review of caus-
22. Delanghe G, Ghyselen J, Feenstra L, van Steenberghe D. es, diagnoses, and treatments. J Calif Dent Assoc
Experiences of a Belgian multidisciplinary breath odour 2007;35:258–268.
clinic. Acta Otorhinolaryngol Belg 1997;51:43–48. 42. Liu XN, Shinada K, Chen XC, Zhang BX, Yaegaki K, Kawa-
23. Dosunmu EB. Management of halitosis secondary to peri- guchi Y. Oral malodour related parameters in the Chinese
odontal disease: report of four cases. Nigerian Dent J general population. J Clin Periodontol 2006;33:31–36.
2009;17:69–71. 43. Loesche WJ, De Boever EH. Strategies to identify the main
24. Eldarrat A, Alkhabuli J, Malik A. The prevalence of self-report- microbial contributors to oral malodour. In: Rosenberg M
ed halitosis and oral hygiene practices among Libyan stu- (ed). Bad breath: research perspectives. Tel-Aviv: Ramot
dents and office workers. Libyan J Med 2008;3:170–176. Publishing, 1995:41–54.
25. Faveri M, Hayacibara MF, Pupio GC, Cury JA, Tsuzuki CO, 44. Loesche WJ, Kazor C. Microbiology and treatment of hali-
Hayacibara RM. A cross-over study on the effect of various tosis. Periodontol 2000 2002;28:256–279.
therapeutic approaches to morning breath odour. J Clin 45. Luqman M. Systemic origin of halitosis: a review. Int J Clin
Periodontol 2006;33:555–560. Dent Sci 2012;3:15–19.
26. Feller L, Blignaut E. Halitosis – a review. SADJ 2005;60:1 46. Masdea L, Kulik EM, Hauser- Gerspach I, Ramseier AM,
7–19. Filipi A, Waltimo T. Antimicrobial activity of Streptocococ-
27. Feng X, Chen X, Cheng R, Sun L,Zhang Y, He T. Breath cus salivarius K12 on bacteria involved in oral malodour.
malodor reduction with use of a stannous-containing so- Arch Oral Biol 2012;57:1041–1047.
dium fluoride dentifrice: A meta-analysis of four rand- 47. Mbodj EB, Faye B, Faye D, Seck MT, Sarr M, Ndiaye C, Dabo
omized and controlled clinical trials. Am J Dent RS, Diallo PD. Prevalence of halitosis in patients with den-
2010;23(special issue B):27B–31B. tal prostheses in Senegal. Med Trop 2011;71:272–274.
28. Frascella J, Gilbert R, Fernandez P. Odor reduction poten- 48. McDowell JD, Kassebaum DK. Diagnosing and treating
tial of a chlorine dioxide mouthrinse. J Clin Dent 1998;9: halitosis. J Am Dent Assoc 1993;124:55–64.
39–42.
49. Meningaud JP, Bado F, Favre E, Bertrand JC, Guilbert F.
29. Haraszthy VI, Gerber D, Clark B, Moses P, Parker C, Halitosis in 1999. Rev Stomatol Chir Maxillofac
Sreenivasan PK, Zambon JJ. Characterization and preva- 1999;100:240–244.
lence of Solobacterium moorei associated with oral halito-
sis. J Breath Res 2008; Mar 2(1):017002. 50. Miyazaki H, Arao M, Okamura K, Kawaguchi Y, Toyofuku A,
Hoshi K et al. Tentative classification of halitosis andits
30. Hughes FJ, McNab R. Oral malodour—a review. Arch Oral treatment needs. Niigata Dent J 1999;32:7–11.
Biol 2008;53(suppl 1):S1–S7.
51. Miyazaki H, Sakao S, Katoh Y, Takehara T. Correlation be-
31. Hyun-Kyung K, Jae-Woo P, Seong-Woo Y, Bong-Ha, Jinsung tween volatile sulphur compounds and certain oral health
K. Deodorizing effect of several antibacterial medicinal measurements in the general population. J Periodontol
herbs on oral malodor. J Korean Oriental Med 2010;31: 1995;66:679–684.
151–163.
52. Mouthwashes. Consumer Reports 1992 (Sept):607–610.
32. Iwamoto T, Suzuki N. Tanabe K, Takeshita T, Hirofuji T. Ef-
fects of probiotic Lactobacillus salivarius WB21 on halito- 53. Nachnani S. The effects of oral rinses on halitosis. J Calif
sis and oral health: an open-label pilot trial. Oral Surg Oral Dent Assoc 1997;25:145–150.
Med Oral Pathol Oral Radiol Endod 2010;110:201–208. 54. Nachnani S. Oral malodor: causes, assessment, and
33. Jindal V, Gautam, Singh A, Tuli A. Breath odour-A Review. treatment. Compendium of Continuing Education in Den-
Indian J Dent Sci 2009;1:23–27. tistry. January/February 2011. Available at http://www.
cdeworld.com/courses/4493-oral-malodor-causes-as-
34. John M, Vandana KL. Detection and measurement of oral sessment-and-treatment#sthash.l7XAr8YD.dpuf, Ac-
malodour in periodontitis patients. Indian J Dent Res cessed March 15 2013.
2006;17:2–6.
55. Odai CD, Azodo CC, Osazuwa-Peters N, Obuekwe ON.
35. Kapoor A, Grover V, Malhotra R, Kaur S, Singh K. Halitosis Characteristics and treatment outcome of patients with
revisited. Indian J Dent Sci 2011;3:102–111. halitosis at a sub-urban health facility. Int J Biomed Health
36. Kazor CE, Mitchell PM, Lee AM, Stokes LN, Loesche WJ, Sci 2010;6:181–190.
Dewhirst FE, Paster BJ. Diversity of bacterial populations 56. Pedrazzi V, Sato S, de Mattos M da G, Lara EH, Panzeri
on the tongue dorsa of patients with halitosis and healthy H.Tongue-cleaning methods: a comparative clinicaltrial
patients. J Clin Microbiol 2003;41:558–563. employing a toothbrush and a tongue scraper. J Periodon-
37. Khaira N, Palmer RM, Wilson RF, Scott DA, Wade WG. Pro- tol 2004;75:1009–1012.
duction of volatile sulphur compounds in diseased perio- 57. Persson S, Edlund MB, Claesson R, Carlsson J. The forma-
dontal pockets is significantly increased in smokers. Oral tion of hydrogen sulfide and methyl mercaptan by oral bac-
Dis 2000;6:371–375. teria. Oral Microbiol Immunol 1990;5:195–201.
38. Knaan T, Cohen D, Rosenberg M. Predicting bad breath in the 58. Porter SR, Scully C. Oral malodour (halitosis). BMJ
non-complaining population. Oral Dis 2005;11:105–106. 2006;333:632–635.
39. Koshimune S, Awano S, Gohara K, Kurihara E, Ansai T, 59. Quirynen M. Management of oral malodour. J Clin Perio-
Takehard T. Low salivary flow and volatile sulfur com- dontol 2003;30(suppl 5):17–18.
pounds in mouth air. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod 2003;96:38–41. 60. Quirynen M, Avontroodt P, Soers C, Zhao H, Pauwels M,
Coucke W, van Steenberghe D. The efficacy of amine fluor-
ide/stannous fluoride in the suppression of morning
breath odour. J Clin Periodontol 2002;29:944–954.
61. Quirynen M, Dadamio J, Van den Velde S, De Smit M, De- 80. Söder B, Johansson B, Söder PO. The relation between
keyser C, Van Tornout M, Vandekerckhove B. Characteris- foetor ex ore, oral hygiene and periodontal disease. Swed
tics of 2000 patients who visited a halitosis clinic. J Clin Dent J 2000;24:73–82.
Periodontol 2009;36:970–975. 81. Sterer N, Nuas S, Mizrahi B, Goldenberg C, Weiss EI,
62. Rassameemasmaung S, Phusudsawang P, Sangalungkarn Domb A, Perez Davidi M. Oral malodor reduction by a pala-
V. Effect of Green tea mouthwash on oral malodour. Prev tal mucoadhesive tablet containing herbal formulation. J
Med 2013;975148. Available at http://doi. Dent 2008;36:535–539.
org/10.5402/2013/975148. Accessed April 27 2013. 82. Sterer N, Ovadia O, Weiss EI, Perez Davidi M. Day-long reduc-
63. Rayman S, Almas K. Halitosis among racially diverse pop- tion of oral malodor by a palatal mucoadhesive tablet con-
ulations: an update. Int J Dent Hygiene 2008;6:2–7. taining herbal formulation. J Breath Res 2013; 7:026004.
64. Roldan S, Herrera D, Sanz M. Biofilms and the tongue: 83. Sterer N, Rosenberg M. Streptococcus salivarius pro-
therapeutical approaches for the control of halitosis. Clin motes mucin putrefaction and malodor production by Por-
Oral Invest 2003;7:189–197. phyromonas gingivalis. J Dent Res 2006;85:910–914.
65. Roldan S, Winkel EG, Herrara D, Sanz M, van Winkehoff AJ. 84. Struch F, Schwahn C, Wallaschofski H, Grabe HJ, Völzke H,
The effects of new mouthrinse containing chlorhexidine, Lerch MM, Meisel P, Kocher T. Self-reported halitosis and
cetylpyridium chloride and zinc lactate on the microflora of gastro-esophageal reflux disease in the general popula-
oral halitosis patients: a dual-centre, double blind placebo tion. J Gen Intern Med 2007;23:260–266.
controlled study. J Clin Periodontol 2003;30:427–434. 85. Takeshita T, Suzuki N, Nakano Y, Shimazaki Y, Yoneda M,
66. Rosenberg M. Clinical assessment of bad breath: current Hirofuji T, Yamashita Y. Relationship between oral malodor
concepts. J Am Dent Assoc 1996;127:475–482. and the global composition of indigenous bacterial popula-
67. Rosenberg M. Science of bad breath. Scientific Am tions in saliva. Appl Environ Microbiol 2010;76:2806–
2002;286:72–79. 2814.
68. Rosenberg M, Knaan T, Cohen D. Association among bad 86. Tanaka M, Toe M, Nagata H, Ojima M, Kuboniwa M, Shimi-
breath, body mass index, and alcohol intake. J Dent Res zu K, Osawa K, Shizukuishi S. Effect of eucalyptus-extract
2007;86:997–1000. chewing gum on oral malodor: a double-masked, rand-
omized trial. J Periodontol 2010;81:1564–1571.
69. Rosenberg M, Septon I, Eli I, Bar-ness R, Gelernter I, Bren-
ner S, Gabbay J. Halitosis measurement by an industrial 87. Tangerman A. Halitosis in medicine: a review. Int Dent J
sulphide monitor. J Periodontol 1991;62:487–489. 2002;52(suppl 3):201–206.
70. Rösing CK, Gomes SC, Bassani DG, Oppermann RV. Effect of 88. Tangerman A, Winkel EG. Intra- and extra-oral halitosis:
chewing gums on the production of volatile sulfur compounds finding of a new form of extra-oral blood-borne halitosis
(VSC) in vivo. Acta Odontol Latinoam 2009;22:11–14. caused by dimethy sulphide. J Clin Periodontol 2007;34:
748–755.
71. Rösing CK, Loesche W. Halitosis: an overview of epidemi-
ology, etiology and clinical management. Braz Oral Res 89. Tyrrell KL, Citron DM, Warren YA, Nachnani S, Goldstein
2011;25:466–471. EJ. Anaerobic bacteria cultured from the tongue dorsum of
subjects with oral malodor. Anaerobe 2003;9:243–246.
72. Samnieng P, Ueno M, Shinada K, Zaitsu T, Kawaguch Y. Dai-
ly variation of oral malodour and related factors in communi- 90. Uguru C, Umeanuka O, Uguru NP, Adigun O, Edafioghor O.
ty-dwelling elderly Thai. Gerodontol 2012;29:e964–e971. The delusion of halitosis: experience at an eastern Nigeria
tertiary hospital. Nigerian J Med 2011;20:236–240.
73. Sanz M, Roldan S, Herrera D. Fundamentals of breath
malodour. J Contemp Dent Pract 2001;2:1–17. 91. Vandana KL, Sridhar A. Oral malodour: a review. J Clin Di-
agnos Res 2008;2:768–773.
74. Scully C, Felix DH. Oral medicine-update for the dental
practitioner: oral malodour. Br Dent J 2005;199:498–500. 92. Van Steenberghe D, Avontroodt P, Peeters W, Pauwels M,
Coucke W, Lijnen A, Quirynen M. Effect of different mouth
75. Settineri S, Mento C, Gugliotta SC, Saitta A, Terranova A, rinses on morning breath. J Periodontol 2001;72:1183–
Trimarchi G, Mallamace D. Self-reported halitosis and 1191.
emotional state: impact on oral conditions and treat-
ments. Health Qual Life Outcomes 2010;8:34. 93. Washio J, Sato T, Koseki T, Takahashi N. Hydrogen sulfide
producing bacteria in tongue biofilm and their relationship
76. Shin K, Yaegaki K, Murata T, Ii H, Tanaka T, Aoyama I, with oral malodour. J Med Microbiol 2005;54:889–895.
Yamauchi K, Toida T, Iwatsuki K. Effects of a composition
containing lactoferrin and lacto peroxidase on oral malo- 94. Yaegaki K, Coil JM. Examination, classification, and treat-
dor and salivary bacteria: a randomized, double-blind, ment of halitosis: clinical perspectives. J Can Dent Assoc
crossover, placebo-controlled clinical trial. Clin Oral Inves- 2000;66:257–261.
tig 2011;15:485–493. 95. Yaegaki K, Sanada K. Biochemical and clinical factors in-
77. Shinada K, Ueno M, Konishi C, Takehara S, Yokoyama S, fluencing oral malodor in periodontal patients. J Periodon-
Kawaguchi Y. A randomized control double blind, crosso- tol 1992;63:783–789.
ver, placebo-controlled clinical trial to assess the effects 96. Yaegaki K, Sanada K. Volatile sulphur compounds in
of a mouthwash containing chlorine dioxide on oral malo- mouth air from clinically healthy subjects and patients
dor. Trials 2008;9:71. with periodontal disease. J Periodontol Res 1992;27:
78. Shinada K, Ueno M, Konishi C, Takehara S, Yokoyama S, 233–238.
Zaitsu T, Ohnuki M, Wright FAC, Kawaguchi Y. Effects of a 97. Zürcher A, Fillipi A. Findings, diagnoses and results of a
mouthwash with chlorine dioxide on oral malodor and sali- halitosis clinic over a seven year period. Schweiz Monats-
vary bacteria: a randomized placebo controlled 7-day trial. schr Zahnmed 2012;122:205–210.
Trials 2010;11:14.
79. Silwood CJ, Grootveld MC, Lynch E. A multifactorial investiga-
tion of the ability of oral health care products (OHCPs) to al-
leviate oral malodour. J Clin Periodontol 2001;28:634–641.